Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN D MAHAN

Allopathic & Osteopathic Physicians Pediatrics Pediatric Nephrology

NPI
1023002417
CMS profile
933209
Location
COLUMBUS, OH

General Payments · PY2019–2024

$80,203.96

  • Reported across 66 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$13,996.92

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $12,925.00 2
Travel and Lodging $724.74 5
Food and Beverage $347.18 7

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Kyowa Kirin, Inc. $12,293.14 12
Alexion Pharmaceuticals, Inc. $1,675.00 1
NOVARTIS PHARMACEUTICALS CORPORATION $28.78 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,320.74 7
PY2020 $19,509.55 17
PY2021 $25,324.11 9
PY2022 $6,719.08 8
PY2023 $10,333.56 11
PY2024 $13,996.92 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $1,675.00 10/15/2024 Consulting Fee Undisputed 01/23/2026 1093956268 CMS
Kyowa Kirin, Inc. $430.78 08/09/2024 Travel and Lodging Undisputed 01/23/2026 1127032979 CMS
Kyowa Kirin, Inc. $226.86 08/09/2024 Travel and Lodging Undisputed 01/23/2026 1127032981 CMS
Kyowa Kirin, Inc. $49.29 08/09/2024 Food and Beverage Undisputed 01/23/2026 1127032991 CMS
Kyowa Kirin, Inc. $119.11 08/09/2024 Food and Beverage Undisputed 01/23/2026 1127032993 CMS
Kyowa Kirin, Inc. $50.00 08/10/2024 Food and Beverage Undisputed 01/23/2026 1127032983 CMS
Kyowa Kirin, Inc. $25.00 08/10/2024 Food and Beverage Undisputed 01/23/2026 1127032987 CMS
Kyowa Kirin, Inc. $25.00 08/10/2024 Food and Beverage Undisputed 01/23/2026 1127032995 CMS
Kyowa Kirin, Inc. $50.00 08/10/2024 Food and Beverage Undisputed 01/23/2026 1127032999 CMS
Kyowa Kirin, Inc. $20.83 08/21/2024 Travel and Lodging Undisputed 01/23/2026 1127032977 CMS
Kyowa Kirin, Inc. $11,250.00 08/21/2024 Consulting Fee Undisputed 01/23/2026 1127032985 CMS
Kyowa Kirin, Inc. $20.61 08/21/2024 Travel and Lodging Undisputed 01/23/2026 1127032989 CMS
Kyowa Kirin, Inc. $25.66 08/21/2024 Travel and Lodging Undisputed 01/23/2026 1127032997 CMS
Novartis Pharmaceuticals Corporation $28.78 05/03/2024 Food and Beverage Undisputed 01/23/2026 1087154576 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.